Cardiovascular diseases are a major cause of health issues and death in the United States and worldwide. While some forms of cardiovascular disease are progressively claiming fewer lives, continued research and preventive measures are needed. Clinical research advances, such as those made in the over 90 cardiovascular trials conducted by ProTrials, help to furtherimprove patients’ lives.
ProTrials is dedicated to advancing cardiology research. Our team has deep experience in the management and monitoring of cardiovascular trials. Our knowledgeencompasses a broad range of indications, including work in all phases of drug development as well as device trials. Trial sizes range from 1 to 700+ sites and 10 to 7000+ subjects globally. Whatever the size or indication, wesuccessfully conductcardiovascular clinical trials worldwide.
64%
of all staff with
Cardiovascular experience
98+
Projects conducted to date
23+
Indications
Indications
Acute Coronary Syndrome
Acute Myocardial Infarction
Acute Renal Failure
Angina Pectoris
Arrythmia
Arterial Closure
Atrial Fibrillation
Cardiac Catheterization
Cardiac Imaging
Congestive Heart Failure
Coronary Artery Bypass Graft
Hepatic Impairment
Hypertrophic Cardiomyopathy
Long Term Anticoagulant Therapy
Myocardial Perfusion Imaging
Paroxysmal Supraventricular Tachycardia
Percutaneous Coronary Intervention
Peripheral Arterial Occlusive Disease
Peripheral Vein Grafts
Pulmonary Arterial Hypertension
Thrombosis
Vascular Stent
Venous Thromboembolism
Virtual and Decentralized Trials
ProTrials leverages virtual trial technology solutions and remote monitoring strategies to improve safety and help put lifesaving clinical trials into action.